Conversely, most evidence supports that decreasing ACAT1 activity actually promotes atherosclerosis, which has been attributed to side effects caused by excess of FC trafficking to the ER membrane, including ER stress, increased synthesis of proinflammatory cytokines, and macrophage death [4]–[7]. The gene discussed is ACAT1; the disease is atherosclerosis.